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Abstract 
Complications of diabetes will result in Diabetic Retinopathy. The patient will not be aware of the symptoms unless it’s too late 
to carryout treatment. Thus early detection of diabetic retinopathy is very essential to prevent vision loss. Fundus examination is 
the major method of diagnosis to detect Microvasculature changes, but a visual functional test is an effective alternative to this 
method which has potential to detect Diabetic retinopathy in early stages. Components of visual function can be characterized in 
by   electrophysiological test of the of the retina. 
Keywords: Diabetic Contrast sensitivity; Diabetic Retinopathy; Diabetes; Dark adaptation; Electroretinogram; Visual evoked 
potential 
 
1. Introduction 
     One of the common complications of diabetes is Diabetic retinopathy (DR). Retinopathy is still a serious cause of 
vision loss [1-2]. Prevention and early treatment of Diabetic retinopathy  is more challenging, since symptoms 
usually  not noticed in the early stages. Diabetic Retinopathy can be of two types, Non-proliferative Diabetic 
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Retinopathy  and Proliferative Diabetic Retinopathy. Early stage of the Diabetic Retinopathy is referred to as Non-
proliferative Diabetic Retinopathy. The advanced stage of DR  is  Proliferative diabetic retinopathy.  
The micro vascular changes and retinal neurodegeneration is a component of DR [3]. The previous studies revealed 
that diabetes increases the rate of apoptosis  of cells in the retina, including neurons. Thus, the Diabetic Retinopathy 
is considered a chronic neurodegenerative disease of the retina. 
       Fundus examination is the major method of diagnosis through which vascular lesions and macular edema can be 
visually noticed but, it does not reveals the  visual functionality. The Diabetic Retinopathy results in  noticeable 
difference in vision in the early stage[4].   The functional components of vision which are altered in measurable 
ways are blurred vision, dark areas in vision, reduced night time vision, impaired colour perception. Due to Diabetic 
Retinopathy the electrophysiological characteristics shown  significant defects in  retinal response to light.  
Visual function can be  checked by retinal response to acuity, dark adaptation, contrast sensitivity, and colour 
contrast. There are data revealing that  these functional parameters is varied in people with diabetes. This  clearly 
shows that variation in the vision functionality have not been fully utilized for detection of DR. 
2. Visual Functionality Checking Methods  
 
 
 
 
 
 
Figure  1.  The types of clinical testing methods of Visual Functionality  
Figure 1. shows the different  clinical testing methods of visual functionality. Each of these methods have a specific 
role in testing visual functionality. The following section describes all these methods briefly.  
    Visual function is checked by a non-invasive functionality called Visual acuity. Visual acuity functionality is 
tested by  using a chart which contains rows of letters of decreasing sizes in each row. Scores reflect the ability of a 
person to identify  individual letters of different sizes in the charts, it indicates the retinal spatial resolution. It is 
observed largely that visual acuity is varied due to diabetic retinopathy and visual angle is doubled with age, period 
of diabetes, severity of diabetic retinopathy.  No major difference was found while comparing the early DR group 
with non-diabetic normal groups. Therefore, Visual acuity is significantly reduced as DR progresses, but this 
sensitivity is insufficient to identify the early stages of DR[5]. 
The retinal ability to uniquely identify  different shades of gray is called contrast sensitivity. Several studies have 
shown reduced contrast sensitivity in diabetic patients[6]. contrast sensitivity test is potentially highly sensitive to 
retinal function compared to that of Visual acuity. contrast sensitivity is thus considered as a  detector of early 
retinal defects. It is reported that while contrast sensitivity testing revealed differences between healthy subjects and 
diabetic subjects with early DR, and diabetes with more progressive DR. However, the test did not shown 
differences between these diabetic sub-groups and therefore may not be able predict the progress of the DR. The 
sensitivity of contrast sensitivity is carried out by comparing scores of non-macular edema subjects and normal 
subjects. This comparison reveals that subjects without macular edema had significantly reduced contrast sensitivity 
scores compared to normal subjects. Unlike Visual acuity testing, contrast sensitivity differences were detected in 
the absence of obvious signs of DR, suggesting greater sensitivity of this test.  
Colour vision, is usually tested with the 100-Hue test, it has been observed that colour vision declines in diabetic 
people. Previous studies has shown some defects in colour vision. However it  did not able to correlate this colour 
vision decline  with respect to the period of diabetes or extremity of Diabetic Retinopathy. The non-proliferative 
diabetic retinopathy patients have experienced significant deficits in blue-yellow colour contrast. Colour sensitivity 
is examined by using clinical electrophysiology also. A flash-on-flash protocol was used in a group of diabetic 
patients but there were no signs of DR, in which a blue spot was paired with a short blue flash on a yellow 
background to isolate the S-cone pathway. The pre-proliferative DR patients experienced decreased response to S-
cone stimulation in comparison with that of age-matched normal subjects. In another approach which used  different 
colours of flash stimuli has resulted in reduction of amplitude of the ERG b-wave of S-cones, in diabetic patients. 
Visual Function 
Visual Acuity Contrast Sensitivity Color Contrast Dark Adaptation 
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but it was unable not correlate this observation with the blood glucose or presence of Diabetic Retinopathy. Thus, it  
suggests a lack of full dependence on vascular pathology and defects in visual function. 
Dark adaptation is the response of the retina  when moving from bright light to low illumination conditions. At low 
levels of light, the rod photoreceptors are active  and its response are  responsible for vision, while the cones are less 
active; this is referred to as scotopic vision. Therefore, dark adaptation is nothing but the adjustments made within 
the retina to result in scotopic vision. Dark adaptation is measured by first subjecting the retina to adapt to darkness 
for some time. Then the retina is stimulated by a bright flash of light the response of the retina is obtained as an 
electrical signal through electrodes mounted at the cornea of the eye. The time taken for the retina to return to a 
specific threshold of sensitivity is measured. In case of early Diabetic Retinopathy it is seen that the response time is 
significantly extended from that of dark adaptation compared to non-diabetic subjects, Thus it is considered as a 
good sensitive marker of early Diabetic Retinopathy [7]. 
By using a dark adaptometer to measure dark adaptation in diabetic subjects   ranging from 3 months to 51 years 
duration, diabetes patients   adaptation to scotopic conditions was delayed and also had elevated thresholds showing 
reduced sensitivity to light.  
Due to more energy consumption and neurotransmitter release from photoreceptors, The retina is  metabolically 
very active during the dark than the light.  Thus it is evident that Diabetic Retinopathy is exacerbated during dark 
adaptation since there increased demand for energy of photoreceptors [8,9]. A recent functional MRI study 
confirmed that a greater metabolic activity is localized to the outer retina in dark-adapted rats, compared to the inner 
retina [10]. In the dark-adapted retina the differential neural activity is affected by diabetes. Visual function which is 
an important aspect has been largely neglected by researchers in Diabetic Retinopathy  research. 
 
 
3. Electrophysiology Methods 
 
 
 
 
 
 
 
 
Figure  2.   Types of Electrophysiological Tests   
Figure 2 Shows the different  types of Electrophysiological clinical testing methods. The following section describes 
all these methods briefly.  
When a light flash falls on the retina, a large amount of photoreceptoral cells are activated. This process includes 
changes in the interlayer currents, determining variations in the trans-retinal voltage: its temporal evolution is 
recorded in the Electroretinogram (ERG). Understanding the specific features (onset, time delay, amplitude, line 
shape) of the ERG components and their relationship represents the principal aim of past and present research in the 
field of ocular electrophysiology[11]. 
 In our earlier paper Umashankar, Panse et al discussed an initial work on analysis of ERG to detect  CSNB and 
Achromatopsia abnormalities of the eye. In this paper we discuss a new system to detect Diabetic Retinopathy [ 12]. 
The Flash ERG illustrated in Figure -3. Is a response recorded using a recording system with a wide frequency 
range, and evoked by a bright flash in order to record all components. The ERP is a rapid discharge recorded with an 
extremely high intensity flash in a well dark – adapted eye using high – frequency amplifiers.  
Electrophysiology  Tests 
 
Flash ERG 
mfERG 
Scotopic Threshold Response 
Flicker ERG 
Visual Evoked Potential 
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Figure  3.  The Elecroretinogram (ERG) Signal 
Table 1.  lists the components of the ERG wave and its origin. The a –wave is a negative potential generated 
extracellularly at the radial path in the cell body of the photoreceptors which hyperpolize as a response to light, and 
is an important parameter of the ERG in  measuring of photoreceptor activity. The  a – wave consists of two 
components i.e., a1 and a2, arising from the cones and rods respectively. 
 
Table 1.  ERG waveform components 
 
Key Full name of component Generator 
ERP Early Receptor Potential Outer segment of 
Photoreceptors 
a1, a2 a - wave a1 – cones, a2 - rods 
OP Oscillatory Potentials Amacrine cells 
x x – wave or b1  
b - wave 
Cells in the inner 
nuclear layer b b – wave or b2 
c c - wave Pigment epithelium 
 
The b – wave is the most readily recordable major component of the clinical ERG. It reflects the postsynaptic 
summed neuronal activity of the inner nuclear layer and is thus an important measure. B – wave consists of two 
components, b1 and b2, representing the cone – mediated and rod – mediated responses respectively. 
The oscillatory potential (OP) appears as a rapid oscillation on the rising phase of the b – wave of the ERG evoked 
by a bright flash. The last oscillation is relatively well defined, can be recorded on a open recorder and is called the 
x – wave or b1. The amacrine cells, the inner plexiform layer and optic nerve fibbers have all been suggested as 
possible generators of the oscillatory potential. 
The c – wave can be seen as a small, slow, positive deflection after the b – wave, although it actually starts slowly 
from the beginning of light stimulation. Briefly the integrity of the pigment epithelium and photoreceptors is an 
essential factor for the generation of the c – wave. 
The Electroretinogram(ERG) is used time and again as a an approach to detect variation of retinal function due to 
diabetes. ERG is  a good predictor of the progression of DR.  ERG measurements have revealed decrease  in the 
amplitude of the b-wave, oscillatory potentials and delay in the implicit times of the ERG waveform in diabetic 
patients. The Scotopic full-field ERG  also shown variation in a-wave, b-wave, and oscillatory potential wave 
amplitudes and implicit times while analyzing differences between diabetic and NPDR subjects compared to 
controls [13]. 
There is good evidence that the amplitude of the scotopic threshold response is reduced in people with diabetes [14-
16]. Some reports of ERG recordings also suggest a decrease in the a-wave amplitude and delayed implicit times in 
diabetic indicating a possible decrease in the magnitude of the photoreceptor response to light [17]. 
Decrease in the amplitude and implicit times of the oscillatory potentials (OPs) are the most consistent ERG changes 
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associated with DR. The OPs are wavelets superimposed along the ascending phase of the b-wave, originated from 
horizontal and amacrine cell activity. The OP's measure is referred to as s a predictor of the onset and progression of 
DR [18-19]. A decrease in both the frequency and amplitude of the OPs, as well as an increase in OPs latency 
indicates inner retinal malfunctioning. 
3.1 The multifocal ERG 
Multi-focal ERGs is a technique used to measure the function of localized portions of the retina.  An alternating 
black or white hexagonal pattern from a ultra-high brightness video monitor is used as stimulus for mfERG. The 
result is displayed  as a 3-diemnsional ERG response “map” or waveforms from multiple regions of the retina 
recovered. This test is handy  in the differential diagnosis of acuity loss,  central serous retinopathy, and age-related 
maculopathy. [20]. The mfERG consists of three major peaks (PI, N1, and P2), signifying bipolar cell activity. 
mfERG of diabetic patients shown  increase  in delay to response revealing malfunction in the localized focal 
regions of the retina [21-23]. Vascular pathology of DR's electrophysiological response is obtained by mfERG. The 
increased delay in response implicit times indicates non-proliferative DR. The mfERG is also been used in 
combination with stereo fundus imaging of non-proliferative retinopathy patients show that areas with abnormal 
ERG responses were contiguous with areas containing vascular lesions [24-26].  
3.2 The scotopic threshold response 
In the measure of retinal function the scotopic threshold response (STR) is  hardly ever used type of an ERG 
waveform, Even though it is very sensitive to inner retinal disorders. The patients are subjected to a long period of  
dark adaptation, thus the measured waveform thereafter is the response to very low intensity flash stimulation. The 
STR is probably originates from inner retina i.e.  retinal ganglion cells and amacrine cells [27]. There is some 
evidence that the amplitude of the STR is reduced in humans with diabetes. This result was found to also occur in 
animals. A study by Kohzaki et al., shown that STR amplitudes were altered in diabetic rats to a greater extent than 
in ERG parameters such as the b-wave amplitude. The discrepancy in the STR of humans and rodents with diabetes 
hinted an inner retinal dysfunction that most likely involves the ganglion cells. More recently, ganglion cell 
malfunction was confirmed in diabetic mice and the STR was used to show that retinal ganglion cells can be rescued 
by pentazocine, a ligand for the sigma receptor. This has shown that the reduced STR amplitude is due to retinal 
ganglion cell apoptosis, and using a neuroprotective drug can also prevent the reduction in the functional output of 
inner retina neurons. 
The STR is is characterized by two waves: positive STR (pSTR), which  possibly reflects ganglion cell activity, and 
negative STR (nSTR), which comes after the pSTR and possibly reflects amacrine cell activity [24,27]. Kohzaki et 
al. verified a reduction in the amplitude of the positive component of the STR of dark-adapted diabetic rats, but no 
difference in the nSTR was observed, signifying that ganglion cell output is modified by diabetes before amacrine 
cell function is affected. This reduction in pSTR may be because of ganglion cell apoptosis, which is a common 
consequence of diabetes [28]. 
 
3.3 Electrophysiological approaches to study dark adaptation 
 
Electrophysiological approaches when applied to diabetic animals   in dark adaptation  [29], Tyrberg and colleagues 
identified a rise flicker response implicit time in dark-adapted diabetic individuals, clearly showing the identifiable 
delay in dark adaptation [30]. Flicker ERG recorded under low intensity conditions also revealed amplitude 
reductions in recordings from diabetic rats, indicating reduced retinal sensitivity to light. Paired-flash ERG 
recording also revealed amplitude reductions, suggesting loss of rod function. 
 
3.4 Visual evoked potentials 
 
The visual evoked potential (VEP) is an electrical signal which is response to a bright flash of light  recorded 
through the skull over the occipital cortex. Changes in the VEP are thought to reflect ganglion cell and optic nerve 
dysfunction and several clinical studies show deficits in humans with diabetes. While this approach is not often 
used, several studies have demonstrated that differences in the VEP exist in humans with diabetes. A small clinical 
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study revealed the presence of functional VEP defects in all diabetic patients, irrespective of the presence of DR 
[31]. A  study on juvenile type 1 diabetic patients  revealed that the VEP amplitude was reduced with an increased 
latency, Then in the absence of vascular retinopathy, the magnitude  deficits in VEP increased with longer durations 
of diabetes [32-34]. These study  suggest that damage to optic nerve function occurs in early stages  of the disease or 
can develop independently from the retinal vascular pathology. 
 
4. Proposed Automated Diabetic Retinopathy Detection System 
 
ERG signal of  Normal subjects of different age group are collected from hospitals and is simulated. The amplitude, 
implicit time and spectrum of ERG are obtained and saved for reference. The patient ERG is simulated and 
compared with the normal ERG parameters.  The proposed system first collects the patient's information such as 
Name, Age  from the then it will consider corresponding age groups normal ERG for analysis. 
     Proposed system  consists of Simulation of ERG signal Sub block, Standard ERG and patient’s ERG are 
simulated in this block using ERG data collected from hospitals. The signal conditioning bock is meant for noise 
removal, if the data of the patient is noisy ERG data. The Signal processing, Measurement and Analysis sub block 
does analysis of the signal using the algorithms developed to obtain the variation in amplitude value and delay in 
response compared to normal ERG. ERG spectrum of normal and patient are also considered for analysis. After 
analyzing it will classify the Diabetic Retinopathy in to one of the types as Proliferative Diabetic Retinopathy 
(PDR)/ Non Proliferic Diabetic Retinopathy depending on the parameter values obtained. The Display of signal and 
parameters sub block will display all the parameters and obtained from the ERG signal with classification of 
Diabetic Retinopathy. The Report generation sub block saves the information along with patient's information   in to 
a file for documentation purpose. 
 
 
 
 
 
 
Fig. 2. Block diagram of the proposed automated Diabetic Retinopathy Detecting System 
 
The proposed system will be a low cost alternative to sophisticated costly equipments used in hospitals for the 
ERG signal analysis purpose. The proposed system  can be readily used in hospitals to classify the Diabetic 
retinopathy accurately since it overcomes observational error or human error during analysis. 
 
5. Conclusion and Future work 
 
 Diabetes affects visual function noticeably. Even though there are limitations, it is evident from components of 
vision, like acuity, dark adaptation, contrast sensitivity, and electrophysiological parameters are differed by diabetes. 
The different measures of visual function have a strong relation with electrophysiological measures compared to 
psychophysical one. Electrophysiological measures is an area which requires more attention even today. For 
instance consider Co-relational studies to compare contrast sensitivity with the ERG, this research area is not been 
explored. Understanding the causes of disease on visual function is an imperative goal in this field of research. It is 
evident that electrophysiological  approach is largely neglected in the Diabetic Retinopathy field. The accurate 
measuring and empirically defining of visual function is very difficult. This could be one of the reasons for the gap 
in research of DR. 
    The proposed system will be very useful for doctors in electrophysiological analysis for better understanding 
of the mechanisms and treatments for vision loss in DR. The proposed system will be implemented and tested with 
Diabetic Retinopathy patient's ERG. The accuracy in classifying Diabetic retinopathy will be obtained. The 
proposed system will be very useful for doctors to analyze ERG signal since they need not have to analyze ERG 
signal manually now. Thus it will overcome the possibility of human errors occurrence during observation of the 
ERG signal. 
 
Simulation of  
ERG Signal 
Signal 
Processing for 
detection & 
A l i f
Display of  
ERG signal  
and parameters  
ERG     
data 
Report 
 Generation 
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